Does QUIZARTINIB Cause Myelosuppression? 8 Reports in FDA Database

Q: Does QUIZARTINIB cause Myelosuppression?

8 reports of Myelosuppression have been filed with the FDA for QUIZARTINIB, representing 2.2% of all QUIZARTINIB adverse event reports.

Q: How dangerous is Myelosuppression from QUIZARTINIB?

Of 8 reports, 1 (12.5%) resulted in death and 5 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Myelosuppression have been filed in association with QUIZARTINIB (VANFLYTA). This represents 2.2% of all adverse event reports for QUIZARTINIB.

Reports of Myelosuppression with QUIZARTINIB

2.2%

of all QUIZARTINIB reports

Deaths

Hospitalizations

How Dangerous Is Myelosuppression From QUIZARTINIB?

Of the 8 reports, 1 (12.5%) resulted in death, 5 (62.5%) required hospitalization.

Is Myelosuppression Listed in the Official Label?

Yes, Myelosuppression is listed as a known adverse reaction in the official FDA drug label for QUIZARTINIB.

What Other Side Effects Does QUIZARTINIB Cause?

Off label use (47) No adverse event (40) Death (32) Platelet count decreased (27) Nausea (25) Disease progression (20) Pyrexia (20) Electrocardiogram qt prolonged (19) Febrile neutropenia (19) Product dose omission issue (18)

What Other Drugs Cause Myelosuppression?

CYCLOPHOSPHAMIDE (3,603) CARBOPLATIN (2,624) TRASTUZUMAB (2,552) PACLITAXEL (2,522) TISLELIZUMAB (2,142) CYTARABINE (1,869) VENETOCLAX (1,864) CISPLATIN (1,849) BEVACIZUMAB (1,744) SODIUM (1,696)

Which QUIZARTINIB Alternatives Have Lower Myelosuppression Risk?

QUIZARTINIB vs RABEPRAZOLE QUIZARTINIB vs RACECADOTRIL QUIZARTINIB vs RADIATION THERAPY QUIZARTINIB vs RADIUM RA-223 DICHLORIDE QUIZARTINIB vs RALOXIFENE

QUIZARTINIB Full Profile All Myelosuppression Reports All Drugs Causing Myelosuppression QUIZARTINIB Demographics